Trial intelligence / Profile preview

Long-Term Safety and Efficacy of Biogeneric Epoetin (GerEPO) for Renal Anemia

NCT00238043Phase 3Unknown

Sponsor
Ministry of Health Malaysia
Start
Aug 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of erythropoietin in Anemia In Chronic Kidney Disease, sponsored by Ministry of Health Malaysia. Status: unknown.

02

Drugs

erythropoietin
03

Conditions

Anemia In Chronic Kidney Disease

Beyond the preview

Go deeper on NCT00238043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00238043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call